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Abstract
Background: Interstitial deletions of 3q29 have been recently described as a microdeletion syndrome mediated by nonallelic
homologous recombination between low-copy repeats resulting in an ~1.6 Mb common-sized deletion. Given the molecular
mechanism causing the deletion, the reciprocal duplication is anticipated to occur with equal frequency, although only one family
with this duplication has been reported.
Results: In this study we describe 14 individuals with microdeletions of 3q29, including one family with a mildly affected mother
and two affected children, identified among 14,698 individuals with idiopathic mental retardation who were analyzed by array
CGH. Eleven individuals had typical 1.6-Mb deletions. Three individuals had deletions that flank, span, or partially overlap the
commonly deleted region. Although the clinical presentations of individuals with typical-sized deletions varied, several features
were present in multiple individuals, including mental retardation and microcephaly. We also identified 19 individuals with
duplications of 3q29, five of which appear to be the reciprocal duplication product of the 3q29 microdeletion and 14 of which
flank, span, or partially overlap the common deletion region. The clinical features of individuals with microduplications of 3q29
also varied with few common features. De novo and inherited abnormalities were found in both the microdeletion and
microduplication cohorts illustrating the need for parental samples to fully characterize these abnormalities.
Conclusion: Our report demonstrates that array CGH is especially suited to identify chromosome abnormalities with unclear
or variable presentations.
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Introduction
Interstitial deletions of 3q29 have recently been described
as a new microdeletion syndrome [1]. Eight cases have
been reported in the literature [1-3]. Although the dele-
tion size is the same in all cases studied (1.6 Mb), the phe-
notype is variable, with mild to moderate mental
retardation the only feature common to all individuals.
However, most individuals exhibit mildly dysmorphic
features, including a long, narrow face, short philtrum,
high nasal bridge, and large ears. Speech delay, autistic
traits, chest-wall deformities, ungainly or ataxic gait, and
long and tapering fingers were each described in at least
two individuals. Several anomalies, such as microcephaly,
cleft lip and palate, recurrent middle ear infections, liga-
mentous laxity, abnormal skin pigmentation, horseshoe
kidney and hypospadias, have been described in individ-
ual patients.
The 3q29 interstitial deletion region encompasses five
known genes and at least 17 transcripts with unknown
functions and is flanked by two highly homologous
region-specific low-copy repeats (LCRs) [1]. The presence
of LCRs flanking the deletions in all subjects suggests that
microdeletions of 3q29 arise via nonallelic homologous
recombination (NAHR) between LCRs on either side of
the breakpoint [4,5]. LCRs flank a number of rearrange-
ment "hotspots." The most well-studied region prone to
rearrangement is 17p12; 24-kb repeats flank a 1.5-Mb
region, deletion of which results in hereditary neuropathy
with liability to pressure palsies (HNPP), whereas dupli-
cation of the same region results in Charcot-Marie-Tooth
disease type 1A [6]. If NAHR between flanking LCRs is
indeed the mechanism underlying deletions of 3q29,
reciprocal duplications of the same interval would be
expected to occur with equal frequency. Recently a three-
generation family was identified in which five individuals
had microduplications that overlapped the region typi-
cally deleted in 3q29 microdeletion syndrome [7]. Com-
mon clinical features included mild/moderate mental
retardation and microcephaly.
In our diagnostic laboratory we have analyzed 14,698
cases by array CGH using a microarray which includes a
high resolution, near-tiling-path coverage of the entire 5.7
Mb of 3q29. Herein, we report the identification of 14
individuals with microdeletions of 3q29 in addition to 19
individuals with duplications of 3q29, five of which
appear to be the reciprocal duplication product of the
3q29 microdeletion and 14 with duplications that flank,
span, or partially overlap the common deletion region.
Subjects and Methods
Patients and controls
During the period encompassing March 2004 through
September 2007, we screened 14,698 consecutive individ-
uals with developmental disabilities whose clinical speci-
mens were submitted to our laboratory from the United
States and abroad. The most common clinical presenta-
tions of the individuals referred for testing were mental
retardation, developmental delay, or multiple congenital
anomalies. Most subjects had previous normal cytoge-
netic analysis, subtelomere FISH, and/or locus-specific
FISH. For the individuals with 3q29 abnormalities
described here, informed consent was obtained using a
Signature Genomic Laboratories consent form to perform
high-resolution molecular cytogenetic testing and to pub-
lish photographs.
BAC Array CGH
Array CGH was performed with a bacterial artificial chro-
mosome (BAC) microarray (the SignatureChip®; Signa-
ture Genomic Laboratories, Spokane, WA) that was
developed for the detection of microdeletions, microdu-
plications, aneuploidy, unbalanced translocations, and
subtelomeric and pericentromeric copy-number altera-
tions [8]. The current version of the SignatureChip, the
SignatureChip Whole Genome™ (SignatureChipWG),
contains 4670 BACs representing 1543 loci with each
locus being represented by a minimum of three overlap-
ping clones. The subtelomeric and pericentromeric
regions are represented with a higher density of overlap-
ping BAC clones, targeted to the unique sequences adja-
cent to these repetitive regions and consisting of contigs of
clones located approximately every 0.5 Mb spanning
more than 5 Mb. Genes in important developmental
pathways are also covered by contigs of BACs to fill in the
chromosome arms and provide higher resolution with an
average gap size between contigs of ~1.6 Mb [8].
Microarray analysis was performed as described [8], with
the following modifications: Briefly, genomic DNA was
extracted from peripheral blood using a Qiagen M48
Biorobot automated DNA extraction system. Purified
genomic DNA was then sonicated and labeled with Alex-
aflour dyes 555 or 647 using a BioPrime Total DNA labe-
ling kit (Invitrogen Corp). Microarrays were hybridized as
previously described (8) and washed using a Little Dipper
automated microarray washing station (SciGene). Micro-
arrays were scanned on an Axon 4000B scanner (Molecu-
lar Devices) and signal intensity ratios were analyzed as
described (8) using a custom analysis and display inter-
face (Genoglyphix™).
FISH
All abnormalities detected by array CGH were confirmed
and visualized by metaphase or interphase fluorescence in
situ hybridization (FISH) using one or more BAC clones
determined to be abnormal by array CGH [9].Molecular Cytogenetics 2008, 1:8 http://www.molecularcytogenetics.org/content/1/1/8
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Oligonucleotide Array CGH
Oligonucleotide array CGH was performed using a cus-
tom-designed microarray (Agilent Technologies, Santa
Clara, USA) on 30 samples in which an abnormality of
3q29 was detected by BAC array CGH. The microarray
consisted of ~13,000 60-mer oligonucleotide probes
spanning ~5.7 Mb of 3q29, with an average probe spacing
of 430 bp. Regions of 3q29 not represented by oligonucle-
otides on the high-density 3q29 microarray consist prima-
rily of regions of large segmental duplication, such as
LCRs, or gaps in the human genome sequence assembly.
However, the lack of coverage in some of these regions
was mitigated by the placement of oligos within a few
hundred basepairs of the LCRs.
Genomic DNA labeling was performed as described for
BAC arrays whereas array hybridization and washing was
performed as specified by the manufacturer (Agilent Tech-
nologies) for 8-plex CGH microarrays. Arrays were
scanned using an Axon 4000B scanner (Molecular
Devices) and analyzed using Agilent Feature Extraction
software v9.5.1 and Agilent CGH Analytics software
v3.5.14.
Results
We identified 14 individuals with microdeletions of 3q29
amongst our patient population, including one family
with a mildly affected mother and two affected children
(Fig. 1B). We characterized 13 of the 14 deletions in more
detail using a high-density oligonucleotide microarray
(insufficient DNA was available for testing of the mother
of the two affected children). Eleven individuals had typ-
ical 1.6 Mb deletions. Both BAC and oligo arrays con-
firmed that these eleven deletions had breakpoints
flanked by segmental duplications known to mediate the
common-sized microdeletion of 3q29 (Fig. 1D). Of the
other deletions, one ~1.4 Mb deletion was within the
common deletion region with only its proximal break-
point flanked by LCRs, one ~1.5 Mb deletion overlapped
the proximal end of the common deletion region by ~500
kb and extended more proximally, and one deletion > 3.2
Mb in size flanked the proximal end of the commonly
deleted region (Fig. 1D). Neither the 1.5 Mb deletion nor
the 3.2 Mb deletion has breakpoints flanked by LCRs. We
confirmed a deletion in all 14 individuals by FISH. Of the
eight individuals for whom parental samples were availa-
ble for analysis, five had de novo abnormalities, all of
which were the common-sized deletion. FISH also identi-
fied a deletion of 3q29 in the mother of the two siblings
with microdeletion of 3q29. BAC microarray analysis of
the father of the individual with the > 3.2 Mb proximal
deletion showed the same deletion, indicating that the
patient's deletion was paternally derived.
Clinical information was available for seven individuals
with the typical 1.6 Mb deletion (Table 1). The clinical
features common to three or more individuals in our
cohort include microcephaly or small head, large low-set
and posteriorly rotated ears, wide nasal bridge, and lan-
guage delay. High-arched palate, widely spaced teeth,
clumsy gait, head banging, macrocephaly, patent ductus
arteriosus, chest cavity deformity, and hypospadias were
identified in one or two individuals (Table 1).
We also identified 19 individuals with microduplications
of 3q29 (Fig. 1C). We analyzed 17 of the 19 microdupli-
cations of 3q29 using the high-density 3q29 oligo array to
refine the breakpoints (Fig. 1E). The high-resolution
microarray identified 12 different duplication sizes that
range in size from 200 kb to 2.4 Mb and which flank,
span, or partially overlap the commonly deleted region.
We also identified five cases which appear to be the recip-
rocal duplication product of the 3q29 microdeletion
because they are flanked by the LCRs which mediate the
common microdeletion of 3q29. Although five other
microduplications of 3q29 have one breakpoint that is
flanked by an LCR, only the reciprocal duplications have
both breakpoints flanked by LCRs (Fig. 1E).
For the 10 individuals with 3q29 microduplications for
whom parental DNA was available for microarray analy-
sis, two had de novo abnormalities. The three reciprocal
3q29 duplications for which parental samples were avail-
able for testing were all inherited from a parent.
Clinical information was available for seven individuals
with microduplications of 3q29, three of whom had the
reciprocal product of the common-sized deletion. The
only clinical feature common to these three individuals
was mild to moderate mental retardation (Table 2).
Among individuals with microduplications of different
sizes, craniosynostosis, high palate, seizures, and ventricu-
lar septal defect were each identified twice.
Discussion
High-resolution microarray analysis has facilitated the
identification of multiple new microdeletion/microdupli-
cation syndromes in individuals with idiopathic mental
retardation and congenital anomalies [10-13]. Because it
is not reliant on clinical suspicion of a known syndrome,
microarray analysis can identify the underlying genomic
lesion in affected individuals for whom a diagnosis has
not been possible – because the rarity of the causative
chromosomal abnormality may prevent accurate report-
ing of index cases in the literature or because the variabil-
ity or mildness of the phenotype escapes characterization.
Among individuals with microdeletions of 3q29, the phe-
notype varies widely, with mild to moderate mental retar-Molecular Cytogenetics 2008, 1:8 http://www.molecularcytogenetics.org/content/1/1/8
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Summary of array CGH results on individuals with microdeletions and microduplications of 3q29 Figure 1
Summary of array CGH results on individuals with microdeletions and microduplications of 3q29. (A) Ideogram of chromosome 3 showing the location of 
the 3q29 cytogenetic band. (B) Representative SignatureChipWG result plot for an individual with a single copy loss of 11 BAC clones spanning the entire 
1.6 Mb common microdeletion region. Each clone represented on the array is arranged along the x-axis according to its location on chromosome 3 with 
the most distal/telomeric p-arm clones on the left and the most distal/telomeric q-arm clones on the right. The blue line represents the ratios for each 
clone from the first experiment (control/patient), and the pink line represents the ratios for each clone obtained from the second experiment in which the 
dyes have been reversed (patient/control). (C) Representative SignatureChipWG result plot for an individual with a single copy gain of 11 BAC clones 
spanning the entire 1.6 Mb common microdeletion region. (D) Diagram showing the deletion sizes of 13 individuals with microdeletions of 3q29 as refined 
using the high-density, custom 3q29 oligonucleotide microarray. Vertical dashed lines in D and E indicate the location of the low-copy repeats (LCRs) in 
the 3q29 interval for which oligonucleotides were not included on the microarray. Blue bars shown at the bottom of the diagram indicate the location of 
paired LCRs within 3q29; their precise orientation is illustrated by arrows. Orange bars indicate the location of other segmental duplications that share no 
homology with any other regions on chromosome 3. LCRs A, B, and C are ~40 kb, ~20 kb, and ~20 kb long, respectively, with > 90% identity to their 
paired counterparts and are simplified for illustrative purposes (based on the Segmental Duplications Database, May 2004 (hg17) draft). (E) Diagram show-
ing the duplication sizes of 17 individuals with microduplications of 3q29 as refined using the high-density, custom 3q29 oligonucleotide microarray. Blue 
arrows show the location of the LCRs that mediate the common 1.6 Mb microdeletion/microduplication and are not drawn to scale. (F-J) Photographs of 
five of the 11 individuals with common-sized microdeletions of 3q29. Individuals shown in F and G are siblings.
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dation/developmental delay, microcephaly, and mild
dysmorphic features (including high nasal bridge and
short philtrum) the only features common to the major-
ity. The lack of an easily discernible clinical phenotype
complicates diagnosis and may explain why so few indi-
viduals with this microdeletion have been identified in
the literature. However, the presence of autistic features in
several individuals [1,2] suggests that a deletion of 3q29
may be considered in individuals with autism. Like that of
the 3q29 microdeletion, the phenotype of the reciprocal
duplication varied, with mental retardation the only com-
mon feature among the three individuals for whom clini-
cal information was available. The careful clinical
examination of additional individuals with these chromo-
some abnormalities are needed to further refine the phe-
notypes.
Table 1: Summary of clinical features found in individuals with common-sized 3q29 microdeletion in this and previous studies.
Feature Number of individuals in present 
study with feature
Number of individuals in previous 
reports with feature
Number of individuals reported to 
date with feature/Number of 
individuals reported to datea
Mild/moderate mental retardation 7 8 15/15
Long, narrow face 0 3 3/15
Short philtrum 0 6 6/15
High nasal bridge 4 5 9/15
Large, low-set, posteriorly rotated 
ears
415 / 1 5
Speech delay 3 5 8/15
Delayed walking 2 5 7/15
Autism/autistic f e a t u r e s 134 / 1 5
Chest-cavity deformities 1 2 3/15
Ataxic gait/gait abnormalities 2 3 5/15
Long, tapering fingers 0 3 3/15
Microcephalya 527 / 1 5
Macrocephaly 1 0 1/15
Cleft lip/palate 0 1 1/15
High-arched palate 2 0 2/15
Widely spaced teeth 2 0 2/15
Recurrent middle ear infections 1 1 2/15
Ligamentous laxity 0 1 1/15
Abnormal skin pigmentation 0 1 1/15
Horseshoe kidney 0 1 1/15
Hypospadias 1 1 2/15
Nasal voice 1 1 2/15
Six lumbar vertebrae 0 1 1/15
Cerebral sigmoid venous 
thrombosis
011 / 1 5
a Includes previous reports [1-3] and patients reported in this paper; b includes reports of progressive microcephaly
Table 2: Summary of clinical features found in individuals with common-sized 3q29 microduplication in this and previous studies.
Feature Number of individuals in present 
study with feature
Number of individuals in previous 
studya with feature
Number of individuals reported to 
date with feature/Number of 
individuals reported to date
Mild/moderate mental retardation 3 3b 6/8
Craniosynostosis 1 0 1/8
Macrocephaly 1 0 1/8
Microcephaly 1 4 5/8
High palate 1 0 1/8
Ventricular septal defect 1 0 1/8
Excessive hand creases 0 2 2/8
Pes planus 0 2 2/8
Obesity 1 3 4/8
a [ref. 7] round face and bulbous nose were also noted, but these traits may be familial; bthree of five family members were old enough for testingMolecular Cytogenetics 2008, 1:8 http://www.molecularcytogenetics.org/content/1/1/8
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Although microduplications have been predicted to occur
with equal frequency as microdeletions that are flanked
by LCRs, fewer have been identified. Those that have been
found tend to result in milder phenotypes than microde-
letions, which may explain in part why microduplication
syndromes appear to be less common than their counter-
parts. Of the 19 microduplications of 3q29 identified by
our laboratory, only five were the reciprocal duplication
of the common-sized deletion of the same region; the
remaining 14 microduplications flanked, overlapped or
were smaller than the common deletion region. These
results suggest that other mechanisms in addition to
NAHR mediate rearrangements of 3q29. A similar situa-
tion occurs in rare rearrangements of 17p11.2 associated
with Smith-Magenis syndrome, in which the breakpoints
do not fall within the paired segmental duplications that
flank most deletions of this region or appear to be medi-
ated by known genomic architectural features [14].
Only two of 10 individuals with microduplications of
3q29 for whom parental DNA was available for testing
had de novo abnormalities. Typically, abnormalities inher-
ited from phenotypically normal parents are considered
benign copy-number variants. However, subclinical phe-
notypes not appreciated in a parent may be manifested
more severely in an affected child; the most common
example is the deletion of 22q11.2 [15]. Therefore, the
clinical significance of the reciprocal 3q29 microduplica-
tion is still unclear. The three-generation family with five
individuals with reciprocal 3q29 microduplications
recently described by Lisi and colleagues [7] would seem
to confirm this duplication is a clinically relevant abnor-
mality. However, the presence of a ~169 kb deletion of
4q13.1 in all affected individuals, and absent in unaf-
fected family members, suggests that the 3q29 microdu-
plication may not be causative of the affected individuals'
phenotypes. Nonetheless, given the rate at which de novo
genomic rearrangements occur in the human population,
a combination of CNVs at the same or different loci,
inherited from parents in whom the single variation was
insufficient to cause disease, might be necessary to pro-
duce a phenotype. A similar hypothesis has been pro-
posed for thrombocytopenia-absent radius (TAR)
syndrome; the authors of a recent study in which 30 indi-
viduals with TAR syndrome had a microdeletion of
1q21.1, 75% of which were inherited from a normal par-
ent, suggest the presence of a genetic modifier in addition
to the 1q21.1 microdeletion was necessary to cause the
disease phenotype [16]. High-resolution whole-genome
screening of a large cohort of affected individuals is
required to determine whether another abnormality is
present elsewhere in the genome.
High-resolution breakpoint mapping using BAC and
oligo-based microarrays identified common and unique
breakpoints in both the 3q29 microdeletion and micro-
duplication cohorts suggesting that other mechanisms in
addition to nonallelic homologous recombination may
play a role in mediating these rearrangements. This study
demonstrates that array CGH is especially suited to iden-
tify chromosome abnormalities in individuals with
unclear or variable presentations.
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